- Home
- PACB vs ABSI Comparison
PACB vs ABSI Comparison
Compare PACB & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PACB
- ABSI
- Stock Information
- Founded
- PACB 2000
- ABSI 2011
- Country
- PACB United States
- ABSI United States
- Employees
- PACB N/A
- ABSI N/A
- Industry
- PACB Biotechnology: Laboratory Analytical Instruments
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- PACB Industrials
- ABSI Health Care
- Exchange
- PACB Nasdaq
- ABSI Nasdaq
- Market Cap
- PACB 381.5M
- ABSI 338.0M
- IPO Year
- PACB 2010
- ABSI 2021
- Fundamental
- Price
- PACB $1.23
- ABSI $2.55
- Analyst Decision
- PACB Buy
- ABSI Strong Buy
- Analyst Count
- PACB 7
- ABSI 5
- Target Price
- PACB $1.90
- ABSI $7.98
- AVG Volume (30 Days)
- PACB 5.1M
- ABSI 3.9M
- Earning Date
- PACB 11-06-2025
- ABSI 11-11-2025
- Dividend Yield
- PACB N/A
- ABSI N/A
- EPS Growth
- PACB N/A
- ABSI N/A
- EPS
- PACB N/A
- ABSI N/A
- Revenue
- PACB $156,110,000.00
- ABSI $4,138,000.00
- Revenue This Year
- PACB $6.15
- ABSI $44.71
- Revenue Next Year
- PACB $15.68
- ABSI $374.26
- P/E Ratio
- PACB N/A
- ABSI N/A
- Revenue Growth
- PACB N/A
- ABSI 27.32
- 52 Week Low
- PACB $0.85
- ABSI $2.01
- 52 Week High
- PACB $2.72
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- PACB 45.49
- ABSI 47.31
- Support Level
- PACB $1.15
- ABSI $2.53
- Resistance Level
- PACB $1.32
- ABSI $2.74
- Average True Range (ATR)
- PACB 0.07
- ABSI 0.17
- MACD
- PACB -0.00
- ABSI 0.03
- Stochastic Oscillator
- PACB 40.00
- ABSI 40.35
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.